Mercado de asparaginasa: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00008224
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 176
Buy Now

Se espera que el mercado de la asparaginasa crezca de 564,01 millones de dólares en 2021 a 1.575,62 millones de dólares en 2028. Se estima que crecerá a una tasa compuesta anual del 16,1% de 2022 a 2028.

La asparaginasa es una enzima que descompone la asparagina. La asparaginasa se usa como medicamento de quimioterapia para tratar la leucemia linfoblástica aguda (LLA), el linfoma linfoblástico (LBL) y algunos otros cánceres de la sangre. A diferencia de las células normales, TODAS las células no pueden producir asparagina. Por lo tanto, la asparaginasa impide que las células cancerosas se dividan y crezcan. La asparaginasa se deriva de Escherichia coli, Erwinia chrysanthemi, asparaginasa pegilada, hongos, algas y otros.

El mercado mundial de la asparaginasa está segmentado según el tipo, la aplicación, la industria de uso final y la geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. Este informe ofrece información y un análisis en profundidad del mercado, haciendo hincapié en parámetros como las tendencias y dinámicas del mercado, y el análisis competitivo de los actores del mercado líderes a nivel mundial.

Información estratégica

Regiones lucrativas para el mercado mundial de asparaginasa

Perspectivas del mercado

El crecimiento significativo de la industria farmacéutica y alimentaria impulsa el mercado mundial de asparaginasa

El sector farmacéutico y La industria alimentaria se ha desarrollado significativamente y ha observado diversos avances para garantizar la alta calidad de los productos alimenticios y farmacéuticos. Según la Federación Europea de Asociaciones e Industrias Farmacéuticas, América del Norte representó el 49% de las ventas farmacéuticas mundiales en 2021 y el 63,7% de las ventas generadas por medicamentos recién lanzados entre 2015 y 2020. Además, la industria farmacéutica se está desarrollando a un ritmo significativo. , respaldado por el aumento de las actividades de I+D y un aumento de la inversión en la industria farmacéutica por parte de los actores del mercado está impulsando aún más el mercado.

La industria alimentaria está en constante expansión con un aumento interminable de alimentos demanda. También hay un aumento continuo de nuevos productos alimenticios. Hoy en día, los fabricantes se centran en la cantidad nutricional de los alimentos. El consumo de alimentos fritos y horneados en todo el mundo ha aumentado sustancialmente, y también ha aumentado la inclinación hacia dichos alimentos. La asparaginasa es el principal aminoácido responsable de reducir el azúcar en alimentos fritos y horneados condensados con fuentes de carbonilo.

Información sobre tipos

Según el tipo, el mercado mundial de asparaginasa se segmenta en Escherichia coli. (E. coli), Erwina Chrysanthemi, Pegylated y otros. El segmento de Escherichia coli tuvo una mayor participación de mercado en 2021, y se prevé que este segmento registre la CAGR más alta del mercado durante el período previsto de 2022-2028, debido a la creciente demanda de asparaginasa derivada de E. coli para el tratamiento del cáncer, como ALL y LBL.

La E. coli derivada de asparaginasa se usa para el tratamiento de leucemias linfoblásticas agudas. La asparaginasa E. coli es una enzima que cataliza la L-asparagina en ácido L-aspártico y amoníaco. Ayuda en la producción de oxaloacetato necesario para el metabolismo celular. La asparaginasa de E. coli tiene una propiedad antitumoral que se utiliza para el tratamiento de leucemias. Por lo tanto, la demanda de asparaginasa E. coli para el tratamiento del cáncer, especialmente en pacientes pediátricos, está impulsando el crecimiento del mercado.

Mercado global de asparaginasa, por tipo: 2021 y 2028

Información sobre aplicaciones

Según la aplicación, el mercado mundial de asparaginasa se divide en terapéutico, procesamiento de alimentos y otros. El segmento terapéutico tuvo una mayor participación del mercado en 2021 y se prevé que este segmento registre la CAGR más alta del mercado debido a su uso en el tratamiento de trastornos linfoproliferativos y linfomas. El segmento se divide aún más en leucemia linfoblástica aguda, linfoma linfoblástico y otros.

La leucemia linfoblástica aguda es un tipo de cáncer de la sangre y la médula ósea, que es mortal si no se trata. Según el Instituto de Medición y Evaluación de la Salud, en 2019 se notificaron alrededor de 153 000 nuevos casos y 47 600 muertes de leucemia linfoblástica aguda en todo el mundo. Por lo tanto, el aumento de los casos de leucemia linfoblástica aguda a nivel mundial está impulsando el crecimiento del mercado mundial de asparaginasa.

< h3>Perspectivas de la industria de uso final

Según el uso final, el mercado mundial de asparaginasa se segmenta en atención médica y fabricación de alimentos. El segmento de atención médica tuvo una mayor participación de mercado en 2021. Además, se espera que el mismo segmento registre la CAGR más alta de 2022 a 2028. El factor impulsor del crecimiento de este segmento es la creciente leucemia linfocítica aguda, el linfoma linfoblástico y la creciente investigación. actividades.

Las estrategias de crecimiento inorgánico observadas en el mercado fueron fusiones y adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión del negocio y la base de clientes de los actores del mercado. A continuación se enumeran algunos de los acontecimientos clave recientes del mercado:

  • En mayo de 2021, Jazz Pharmaceuticals adquirió la empresa farmacéutica GW para mejorar sus capacidades de I+D. Esta adquisición también ayudará a la empresa a desarrollar y comercializar medicamentos recetados a base de cannabinoides.
  • En abril de 2021, Servier completó la adquisición de Agios Pharmaceuticals&rsquo. Regalías de más de 2 mil millones de dólares, incluida la cartera de oncología comercial, clínica y en etapa de investigación. Esta adquisición fortalece la presencia comercial de Servier en el mercado de hematología maligna de EE. UU. y ofrece potencial de crecimiento a largo plazo en el espacio de tumores sólidos.
  • En agosto de 2018, Medac GmBH, en asociación con FarmaMondo SA, distribuirá Spectrila exclusivamente a través de un programa de acceso administrado para proveedores de atención médica específicos en Rusia, Georgia, Azerbaiyán, Kirguistán, Uzbekistán y Moldavia. FarmaMondo gestionará el acceso a Spectrila para pacientes con leucemia linfoblástica aguda.

Algunos de los actores clave que operan en el mercado global de asparaginasa incluyen Servier Pharmaceuticals LLC, BioVendor R&D, Creative Enzymes, medac GmbH , Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, Taj Pharmaceuticals Limited y Jazz Pharmaceuticals plc.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Asparaginase?

Asparaginase is an enzyme that breaks down asparagine. Asparaginase is used as a chemotherapy drug to treat acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), and certain other blood cancers. Unlike normal cells, ALL cells are unable to make their own asparagine. Therefore, asparaginase stops the cancer cells from dividing and growing. Asparaginase are derived from Escherichia coli, Erwinia chrysanthemi, pegylated asparaginase, fungi, algae and others.

What are the driving factors for the global asparaginase market across the world?

The factors that are driving the growth of the asparaginase market are rising incidences of leukemia and increasing usage applications and significant growth of the pharmaceutical and food industry are the major factors contributing to the growth of the asparaginase industry.

Who are the major players in the asparaginase market across the globe?

The asparaginase market majorly consists of the players, such as Servier Pharmaceuticals LLC, Jazz Pharmaceuticals plc, BioVendor R&D, Creative Enzymes, medac GmbH, Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, and Taj Pharmaceuticals Limited and among others.

What is the market CAGR value of the asparaginase market during the forecast period?

The CAGR value of the asparaginase market during the forecasted period of 2022-2028 is 16.1%

What is the estimated asparaginase market size in 2021?

The asparaginase market is estimated to be valued at US$ 564.01 million in 2021.

What are the growth estimates for the asparaginase market till 2028?

The asparaginase market is expected to be valued at US$ 1,575.62 million in 2028.

Which segment by type led the asparaginase market?

The Escherichia Coli segment held the largest share of the market in the global asparaginase market contributing a market share of 49.78% in 2021.

Which region is projected to be the fastest-growing region in the global asparaginase market?

The Asia Pacific is expected to be the fastest-growing region in the asparaginase market over the forecast period due to increasing prevalence of acute lymphoblastic leukemia, increasing research activities in cancer, and increasing innovative products for treatment of hematological cancers by the market players in the region.

The List of Companies - Asparaginase Market

  1. Servier Pharmaceuticals LLC
  2. Jazz Pharmaceuticals plc
  3. BioVendor R&D
  4. Creative Enzymes
  5. medac GmbH
  6. Changzhou Qianhong Bio-pharma Co Ltd
  7. United Biotech
  8. Porton Biopharma
  9. Taj Pharmaceuticals Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports